| Literature DB >> 33436221 |
Lili He1, Bingxiong Yan2, Caiyun Yao2, Xiaoyi Chen3, Longwei Li3, Youjiao Wu3, Zhijun Song2, Shanshan Song3, Zhifeng Zhang4, Pei Luo5.
Abstract
Fructooligosaccharide was isolated from Polygonatum Cyrtonema Hua (PFOS) for the first time. Structure characterized using FT-IR, MALDI-TOF-MS, NMR, AFM, and TEM, indicated that PFOS was graminan-type fructan with a degree of polymerization ranging from 5 to 10. A murine model of lipopolysaccharide (LPS)-induced peritonitis was used to evaluate the in vivo anti-inflammatory and lung protective efficacy of PFOS. The result shown that pretreatment with PFOS (1.0 mg/mL) in peritonitis-induced mice could significantly inhibit the level of pro-inflammatory cytokines (TNF-α, IL-1β) in serum (P < 0.001), increase mice survival rate from 12.5 % to 54 % (P < 0.05), and alleviated lung injury through ameliorating the damage of the pulmonary cellular architecture and reducing inflammatory monocyte accumulation in lung tissue. This effect of oligosaccharides could explain the traditional usage of P. cyrtonema as a tonic medicine for respiratory problems and it could be used as a potential natural ingredient with anti-inflammatory activity.Entities:
Keywords: Anti-inflammation; Graminan-type fructan; Lipopolysaccharide mouse model; Lung injury; Peritonistis; Polygonatum Cyrtonema Hua
Mesh:
Substances:
Year: 2020 PMID: 33436221 DOI: 10.1016/j.carbpol.2020.117392
Source DB: PubMed Journal: Carbohydr Polym ISSN: 0144-8617 Impact factor: 9.381